Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Infection and immunity (Impact Factor: 4.16). 08/2009; 77(9):3969-77. DOI: 10.1128/IAI.01362-08
Source: PubMed

ABSTRACT Despite the fact that closely related bacteria can cause different levels of disease, the genetic changes that cause some isolates to be more pathogenic than others are generally not well understood. We use a combination of approaches to determine which factors contribute to the increased virulence of a Bordetella bronchiseptica lineage. A strain isolated from a host with B. bronchiseptica-induced disease, strain 1289, was 60-fold more virulent in mice than one isolated from an asymptomatically infected host, strain RB50. Transcriptome analysis and quantitative reverse transcription-PCR showed that the type III secretion system (TTSS) genes were more highly expressed by strain 1289 than strain RB50. Compared to strain RB50, strain 1289 exhibited greater TTSS-mediated cytotoxicity of a mammalian cell line. Additionally, we show that the increase in virulence of strain 1289 compared to that of RB50 was partially attributable to the TTSS. Using multilocus sequence typing, we identified another strain from the same lineage as strain 1289. Similar to strain 1289, we implicate the TTSS in the increased virulence of this strain. Together, our data suggest that the TTSS is involved in the increased virulence of a B. bronchiseptica lineage which appears to be disproportionately associated with disease. These data are consistent with the view that B. bronchiseptica lineages can have different levels of virulence, which may contribute to this species' ability to cause different severities of respiratory disease.

Download full-text


Available from: Eric T Harvill, Mar 21, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose is to develop an automatic computerized screening system to recognize automatically the main components of the retina, an important features of background diabetic retinopathy and classify the normal, abnormal and unknown retinal image. This paper has presented 4 main methods to succeed of retinal diagnosis. Firstly, the retinal images are preprocessed via adaptive, local, contrast enhancement Secondly, the main features of a retinal image were defined as the optic disc, and blood vessels. The optic discs were located by identifying the area with the highest variation in intensity of adjacent pixels. Blood vessels were identified by means of a multilayer perceptron neural network, for which the inputs were derived from a principal component analysis of the image and edge detection of the intensity. Next, the background diabetic retinopathy features are identified. Recursive region growing segmentation algorithms were applied to detect the hard exudates. The haemorrhages and microaneurysms were recognised by detecting all feature similar to the blood vessels and removed the vessels out. Finally, all information is accumulated and diagnosed for diabetic retinopathy or a normal retina. The diabetic retinopathy screening technique has been applied to the 484 normal retina images and 283 images with diabetic retinopathy. The sensitivity and specificity for the computerized screening program to classify the images were corrected 80.21% and 70.66% respectively. The computerized screening system has been developed to classify the normal and abnormalities of retinal images. The development of getting higher performance is in progress.
    Image and Signal Processing and Analysis, 2003. ISPA 2003. Proceedings of the 3rd International Symposium on; 10/2003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Host immunity is a major driving force of antigenic diversity, resulting in pathogens that can evade immunity induced by closely related strains. Here we show that two Bordetella bronchiseptica strains, RB50 and 1289, express two antigenically distinct O-antigen serotypes (O1 and O2, respectively). When 18 additional B. bronchiseptica strains were serotyped, all were found to express either the O1 or O2 serotype. Comparative genomic hybridization and PCR screening showed that the expression of either the O1 or O2 serotype correlated with the strain containing either the classical or alternative O-antigen locus, respectively. Multilocus sequence typing analysis of 49 B. bronchiseptica strains was used to build a phylogenetic tree, which revealed that the two O-antigen loci did not associate with a particular lineage, evidence that these loci are horizontally transferred between B. bronchiseptica strains. From experiments using mice vaccinated with purified lipopolysaccharide from strain RB50 (O1), 1289 (O2), or RB50Deltawbm (O antigen deficient), our data indicate that these O antigens do not confer cross-protection in vivo. The lack of cross-immunity between O-antigen serotypes appears to contribute to inefficient antibody-mediated clearance between strains. Together, these data are consistent with the idea that the O-antigen loci of B. bronchiseptica are horizontally transferred between strains and encode antigenically distinct serotypes, resulting in inefficient cross-immunity.
    Infection and immunity 07/2009; 77(8):3249-57. DOI:10.1128/IAI.01448-08 · 4.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The outcome of tuberculosis infection and disease is highly variable. This variation has been attributed primarily to host and environmental factors, but better understanding of the global genomic diversity in the M. tuberculosis complex (MTBC) suggests that bacterial factors could also be involved. Review of nearly 100 published reports shows that MTBC strains differ in their virulence and immunogenicity in experimental models, but whether this phenotypic variation plays a role in human disease remains unclear. Given the complex interactions between the host, the pathogen and the environment, linking MTBC genotypic diversity to experimental and clinical phenotypes requires an integrated systems epidemiology approach embedded in a robust evolutionary framework.
    Drug Discovery Today Disease Mechanisms 03/2010; 7(1):e43-e59. DOI:10.1016/j.ddmec.2010.09.004
Show more